FROM REFUGEE TO RECEIVING MULTIPLE ACCOLADES AS A COMMUNITY PHARMACIST
With
Sara Murdock MPS,
Lead Pharmacist,
Pharmacy 777 Pascoe Vale (Melbourne), Victoria
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Melbourne | December 2025
Sara is an experienced pharmacist, community health advocate, and the Lead Pharmacist at Pharmacy 777 Pascoe Vale in Victoria. With over 20 years in the profession, Sara has played a significant role in advancing local healthcare delivery through clinical leadership, service development, and strong community partnerships.
In 2025, Sara was recognised as the VIC Pharmacist of the Year by the Pharmaceutical Society of Australia and the National Winner of the Outstanding Community Pharmacist Award by Patients Australia. Recently, Sara also was awarded the 2025 International Pharmacist of the Year by the Pharmacy Innovation Assembly, are acknowledgements that reflect her growing impact across pharmacy practice.
Sara is a passionate advocate for accessible healthcare, full scope pharmacy practice, and inclusive community services. She has led major health initiatives, including school-based immunisation programs, chronic disease prevention efforts, aged care outreach, and student mentoring programs. She also established the first pharmacist-led vaccination clinic at the local neighbourhood house, expanding care to vulnerable and underserved populations.
Beyond the dispensary, Sara is a key contributor to the national Pharmacy 777 Retail Services Pharmacy Owners Working Group. She collaborates on strategies for patient-centric care, retail innovation, and sustainable business models that support both pharmacists and consumers across Australia.
Her leadership also extends far beyond the pharmacy walls. Sara is an active Rotarian and Chair of Community Services for her local Rotary Club. She is a trusted speaker at Rotary events, parliamentary forums, health panels, universities, and grassroots community gatherings, bringing both lived experience and professional expertise to the conversation.
As a solo mother of two and a dedicated health professional, Sara brings compassion, experience, and clarity of purpose to her work. She is especially committed to supporting the next generation of pharmacists and advocating for systems that deliver better outcomes for patients and communities alike.
Sara’s voice is one of resilience. At just 12 years old, she was smuggled from war-tom Iraq through mountains and borders, arriving in Australia as a child refugee. Her early experiences shaped her enduring belief in equitable healthcare and the power of service, Today, she continues to build a career and legacy rooted in care, contribution, and connection, proving that it’s possible to lead with strength while remaining grounded in humanity.
Source: Supplied and adapted
-
Integrating oral health care across non-dental professionals
Poor oral health can contribute to or exacerbate several systemic health conditions due to the close connection between oral bacteria, inflammation, and systemic processes. These conditions include cardiovascular health, diabetes, respiratory health, cognitive health, pregnancy and birth outcomes.
-
Jack Lancaster, Evolution Surgical
Continuing the Australian Health Journal, People In Health Care series is Jack Lancaster, the CEO of Evolution Surgical, an Australian owned company established in 2014, specialising in spinal fusion implants and custom instrumentation.
Jack talks about how the company works closely with surgeons to design custom solutions manufactured to surgical requirements, and ultimately, to the benefit of the Australia patient.
-
Foundation outlines breast cancer research strategy
Australian Health Journal met with Associate Professor Cleola Anderiesz, CEO of the National Breast Cancer Foundation to hear of the new 5 year Pink Horizon research strategy. Those with lived experience of breast cancer, along with researchers, clinicians, and other funding organisations, have contributed to the development of the foundation’s new five-year Pink Horizon research strategy. This ambitious plan aims to invest $125 million to accelerate research efforts towards the vision of ending deaths from breast cancer.
